These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 33091843)

  • 1. Introduction to the special issue on the HEALing Communities Study.
    El-Bassel N; Jackson RD; Samet J; Walsh SL
    Drug Alcohol Depend; 2020 Dec; 217():108327. PubMed ID: 33091843
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The HEALing (Helping to End Addiction Long-term
    HEALing Communities Study Consortium
    Drug Alcohol Depend; 2020 Dec; 217():108335. PubMed ID: 33248391
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protocol for community-driven selection of strategies to implement evidence-based practices to reduce opioid overdoses in the HEALing Communities Study: a trial to evaluate a community-engaged intervention in Kentucky, Massachusetts, New York and Ohio.
    Young AM; Brown JL; Hunt T; Sprague Martinez LS; Chandler R; Oga E; Winhusen TJ; Baker T; Battaglia T; Bowers-Sword R; Button A; Fallin-Bennett A; Fanucchi L; Freeman P; Glasgow LM; Gulley J; Kendell C; Lofwall M; Lyons MS; Quinn M; Rapkin BD; Surratt HL; Walsh SL
    BMJ Open; 2022 Sep; 12(9):e059328. PubMed ID: 36123106
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Opioid-overdose Reduction Continuum of Care Approach (ORCCA): Evidence-based practices in the HEALing Communities Study.
    Winhusen T; Walley A; Fanucchi LC; Hunt T; Lyons M; Lofwall M; Brown JL; Freeman PR; Nunes E; Beers D; Saitz R; Stambaugh L; Oga EA; Herron N; Baker T; Cook CD; Roberts MF; Alford DP; Starrels JL; Chandler RK
    Drug Alcohol Depend; 2020 Dec; 217():108325. PubMed ID: 33091842
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Health communication campaigns to drive demand for evidence-based practices and reduce stigma in the HEALing communities study.
    Lefebvre RC; Chandler RK; Helme DW; Kerner R; Mann S; Stein MD; Reynolds J; Slater MD; Anakaraonye AR; Beard D; Burrus O; Frkovich J; Hedrick H; Lewis N; Rodgers E
    Drug Alcohol Depend; 2020 Dec; 217():108338. PubMed ID: 33152673
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Health economic design for cost, cost-effectiveness and simulation analyses in the HEALing Communities Study.
    Aldridge AP; Barbosa C; Barocas JA; Bush JL; Chhatwal J; Harlow KJ; Hyder A; Linas BP; McCollister KE; Morgan JR; Murphy SM; Savitzky C; Schackman BR; Seiber EE; E Starbird L; Villani J; Zarkin GA
    Drug Alcohol Depend; 2020 Dec; 217():108336. PubMed ID: 33152672
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Community selected strategies to reduce opioid-related overdose deaths in the HEALing (Helping to End Addiction Long-term
    Chandler R; Nunes EV; Tan S; Freeman PR; Walley AY; Lofwall M; Oga E; Glasgow L; Brown JL; Fanucchi L; Beers D; Hunt T; Bowers-Sword R; Roeber C; Baker T; Winhusen TJ
    Drug Alcohol Depend; 2023 Apr; 245():109804. PubMed ID: 36780768
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Community coalition and key stakeholder perceptions of the community opioid epidemic before an intensive community-level intervention.
    Drainoni ML; Knudsen HK; Adams K; Andrews-Higgins SA; Auritt V; Back S; Barkowski LK; Batty EJ; Behrooz MR; Bell S; Chen S; Christopher MC; Coovert N; Crable EL; Dasgupta A; Goetz M; Goddard-Eckrich D; Hartman JL; Heffer H; Iftikhar P; Jones L; Lang S; Lunze K; Martin A; McCrimmon T; Reedy-Johnson MK; Roeber C; Scalise AL; Sieck CJ; Walker DM; Walt G; Wood JD; Zito P; McAlearney AS
    J Subst Abuse Treat; 2022 Jul; 138():108731. PubMed ID: 35125253
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Community engagement to implement evidence-based practices in the HEALing communities study.
    Sprague Martinez L; Rapkin BD; Young A; Freisthler B; Glasgow L; Hunt T; Salsberry PJ; Oga EA; Bennet-Fallin A; Plouck TJ; Drainoni ML; Freeman PR; Surratt H; Gulley J; Hamilton GA; Bowman P; Roeber CA; El-Bassel N; Battaglia T
    Drug Alcohol Depend; 2020 Dec; 217():108326. PubMed ID: 33059200
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Community dashboards to support data-informed decision-making in the HEALing communities study.
    Wu E; Villani J; Davis A; Fareed N; Harris DR; Huerta TR; LaRochelle MR; Miller CC; Oga EA
    Drug Alcohol Depend; 2020 Dec; 217():108331. PubMed ID: 33070058
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Model and approach for assessing implementation context and fidelity in the HEALing Communities Study.
    Knudsen HK; Drainoni ML; Gilbert L; Huerta TR; Oser CB; Aldrich AM; Campbell ANC; Crable EL; Garner BR; Glasgow LM; Goddard-Eckrich D; Marks KR; McAlearney AS; Oga EA; Scalise AL; Walker DM
    Drug Alcohol Depend; 2020 Dec; 217():108330. PubMed ID: 33086156
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estimated Reductions in Opioid Overdose Deaths With Sustainment of Public Health Interventions in 4 US States.
    Chhatwal J; Mueller PP; Chen Q; Kulkarni N; Adee M; Zarkin G; LaRochelle MR; Knudsen AB; Barbosa C
    JAMA Netw Open; 2023 Jun; 6(6):e2314925. PubMed ID: 37294571
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Addressing opioid overdose deaths: The vision for the HEALing communities study.
    Chandler RK; Villani J; Clarke T; McCance-Katz EF; Volkow ND
    Drug Alcohol Depend; 2020 Dec; 217():108329. PubMed ID: 33075691
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost of start-up activities to implement a community-level opioid overdose reduction intervention in the HEALing Communities Study.
    Montoya ID; Watson C; Aldridge A; Ryan D; Murphy SM; Amuchi B; McCollister KE; Schackman BR; Bush JL; Speer D; Harlow K; Orme S; Zarkin GA; Castry M; Seiber EE; Barocas JA; Linas BP; Starbird LE
    Addict Sci Clin Pract; 2024 Apr; 19(1):23. PubMed ID: 38566249
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mobile addiction treatment and harm reduction services as tools to address health inequities: a community case study of the Brockton Neighborhood Health Center mobile unit.
    Pinkhover A; Celata K; Baker T; Chatterjee A; Lunze K
    Front Public Health; 2024; 12():1407522. PubMed ID: 38957203
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of the Communities that HEAL intervention on receipt of behavioral therapies for opioid use disorder: A cluster randomized wait-list controlled trial.
    Glasgow L; Douglas C; Sprunger JG; Campbell ANC; Chandler R; Dasgupta A; Holloway J; Marks KR; Roberts SM; Martinez LS; Thompson K; Weiss RD; Aldridge A; Asman K; Barbosa C; Blevins D; Chassler D; Cogan L; Fanucchi L; Hall ME; Hunt T; Jadovich E; Levin FR; Lincourt P; Lofwall MR; Loukas V; McAlearney AS; Nunes E; Oga E; Oller D; Rudorf M; Sullivan AM; Talbert J; Taylor A; Teater J; Vandergrift N; Woodlock K; Zarkin GA; Freisthler B; Samet JH; Walsh SL; El-Bassel N
    Drug Alcohol Depend; 2024 Jun; 259():111286. PubMed ID: 38626553
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Using community engagement to implement evidence-based practices for opioid use disorder: A data-driven paradigm & systems science approach.
    El-Bassel N; Gilbert L; Hunt T; Wu E; Oga EA; Mukherjee TI; Campbell ANC; Sabounchi N; Gutnick D; Kerner R; Venner KL; Lounsbury D; Huang TTK; Rapkin B
    Drug Alcohol Depend; 2021 May; 222():108675. PubMed ID: 33757707
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of the Communities that Heal (CTH) intervention on perceived opioid-related community stigma in the HEALing Communities Study: results of a multi-site, community-level, cluster-randomized trial.
    Davis A; Knudsen HK; Walker DM; Chassler D; Lunze K; Westgate PM; Oga E; Rodriguez S; Tan S; Holloway J; Walsh SL; Oser CB; Lefebvre RC; Fanucchi LC; Glasgow L; McAlearney AS; Surratt HL; Konstan MW; Huang TT; LeBaron P; Nakayima J; Stein MD; Rudorf M; Nouvong M; Kinnard EN; El-Bassel N; Tilley J; Macoubray A; Savitzky C; Farmer A; Beers D; Salsberry P; Huerta TR
    Lancet Reg Health Am; 2024 Apr; 32():100710. PubMed ID: 38510790
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Community-level determinants of stakeholder perceptions of community stigma toward people with opioid use disorders, harm reduction services and treatment in the HEALing Communities Study.
    Davis A; Stringer KL; Drainoni ML; Oser CB; Knudsen HK; Aldrich A; Surratt HL; Walker DM; Gilbert L; Downey DL; Gardner SD; Tan S; Lines LM; Vandergrift N; Mack N; Holloway J; Lunze K; McAlearney AS; Huerta TR; Goddard-Eckrich DA; El-Bassel N
    Int J Drug Policy; 2023 Dec; 122():104241. PubMed ID: 37890391
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Operationalizing and selecting outcome measures for the HEALing Communities Study.
    Slavova S; LaRochelle MR; Root ED; Feaster DJ; Villani J; Knott CE; Talbert J; Mack A; Crane D; Bernson D; Booth A; Walsh SL
    Drug Alcohol Depend; 2020 Dec; 217():108328. PubMed ID: 33091844
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.